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Abstract
For use in veterinary medicine for the treatment of the wound process and the prevention of mastitis, the composition and 
technology of an emulsion-based cream, conventionally called «Saprocream», has been developed. Clinical trial of the drug «Sapro-
cream» proved its effectiveness and safety for use in the healing of microtraumas, erosions and cracks (wounds) of the udders of cows.
The aim of the research were was the standardization of the cream under the conventional name «Saprocream» for use in 
veterinary medicine as a wound healing agent, the development of methods of identification and quantification and their validation.
Materials and methods. Test samples of emulsion cream type o/v, containing 15 % aqueous extract of sapropel (VES), 10 % 
oil extract of sapropel (OES), 6 % emulsifier No. 1, 1 % cetylstearyl alcohol, preservatives – 0.01 % nisin, 0.1 % euxil K 100 and 
purified water up to 100 g were made by phase inversion.
The methods of pharmacopoeial articles of the European Pharmacopoeia of the 10th edition, SPhU 1.0, as well as industry 
standards were used to develop methods for identification and quantification of active pharmaceutical ingredients (API) in the de-
veloped cream and its standardization.
Results. The chromatographic profile of the acetone extract from the cream coincides with the chromatographic profile 
of the reference solution ((PRS) β-carotene), which indicates the presence of substances of carotenoid structure. The absorption 
spectrum of hexane extraction from the cream in the range from 500 nm to 750 nm has a maximum absorption at a wavelength of 
670 ± 2 nm, which coincides with the maximum absorption of hexane solution OES, indicating the presence of chlorophyll.
A method for quantifying the total mass fraction of humic acids (HA) has been developed and it has been established that the 
total mass fraction of HA in cream samples with sapropel extracts is 0.828 %.
The results of the validation of the method show that there is a linear relationship between the concentration of the total mass 
fraction of HA and the mass of the AES sample with a correlation coefficient of 0.9981 (³0.9981). The developed technique is precise, 
because the value of the relative confidence interval is less than the critical value for the convergence of the results: D % = 1.34 ≤ 1.60 
and the criterion of insignificance of systematic error d = 0.51 is fulfilled.
Conclusions. An emulsion-based cream under the conventional name «Saprocream» has been standardized, methods for 
identification and quantification of active substances have been developed and validation of the developed methods for use in vete-
rinary medicine as a wound-healing and anti-inflammatory agent has been carried out.
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1. Introduction
The production of pharmaceutical products intended for the needs of veterinary medicine, 
in particular for the treatment and prevention of diseases of farm animals, is a necessary prerequi-
site for the effective functioning of the livestock industry [1, 2].
Unfortunately, the competitiveness of domestically produced veterinary drugs (VD) is low, 
the technological level of Ukrainian producers compared to foreign companies is quite low, which 
explains the small volume of production of domestic VD [1, 3].
Bovine mastitis is an inflammatory disease that affects one or more of the four quarters of 
the bovine mammary gland or udder and can adversely affect the health of cows [4]. Mastitis is the 
most frequent disease of dairy cows and has well-recognized detrimental effects on animal wellbe-
ing and dairy farm profitability [5]. Heifer mastitis is a disease that potentially threatens production 
and udder health in the first and subsequent lactations [6].
Taking into account that lesions on the nipples of the teats of dairy cows can lead to mastitis, 
which is the most common disease in cows, which, in addition to economic losses, poses a danger 
to dairy consumers, the problem of introducing available, effective and safe drugs for the treatment 
and prevention of microtraumas, erosions and cracks in the udder of cows, which reduce the risk 
of mastitis is relevant [7, 8].
The register of veterinary drugs on the website of the State Service of Ukraine for Food Safety 
and Consumer Protection as of June 2021 was analyzed [9]. It is established that according to ATCvet 
classification of group QD03АХ the solution for external application Antiseptic stimulator «Road 
fraction 2» (LLC «AVZ SP», the Russian Federation), nutritious ointment (PJSC «GNP Ukrzoovet-
prompostach», Ukraine), ointment «Zhyvosept» (Private enterprise «OL KAR-AgroZooVet-Ser-
vice», Ukraine), ointment «Vetmekol» (PJSC NVC «Borshchahivsky HFZ», Ukraine) and suspen-
sion «Aluspray» (Vetokvinol SA, France) [10] (Fig. 1).
Fig. 1. Distribution of dermatological VD group QD03AH Other drugs that promote  
wound healing (scarring) by dosage forms 
Semi-solid dosage forms (SDF) are widely used in veterinary practice, as 60 % of the market 
for veterinary drugs is made in the form of ointments [11].
Drugs for external use have certain advantages, including ease of use and monitoring of 
treatment. In addition, most of these drugs do not enter the systemic bloodstream and, accordingly, 
do not cause complications in the body. Interaction with other drugs is also infrequent [12, 13].
Given that lesions on the nipples of the teats of dairy cows can lead to mastitis, which is the most 
common disease in cows, which, in addition to economic losses, poses a danger to dairy consumers, 
the problem of introducing affordable, effective and safe drugs is relevant. treatment and preven-
tion of microtraumas, erosions and cracks in the teats of cows, which reduce the risk of mastitis [1].
For use in veterinary medicine for the treatment of wound process and prevention of masti-
tis, we have developed an emulsion-based cream, tentatively called «Saprocream», containing 15 % 
sapropel oil extract (OES) and 10 % aqueous sapropel extract (AES) [14].
The cream technology was developed and the parameters of the technological process were 
investigated [15].
As a result of studying the anti-inflammatory and wound-healing effect of the cream 
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pronounced anti-inflammatory properties, reduces the intensity of acute photodynamic inflamma-
tion and shortens treatment time [16, 17].
Clinical trials of «Saprocream» have proven its effectiveness and safety for use in the heal-
ing of microtraumas, erosions and cracks (wounds) of teats of cows [18].
A prerequisite for the use of the cream in medicine and pharmacy is its standardization, 
which is a difficult task, as there is no analytical and regulatory documentation governing the qua-
lity of sapropel as a raw material for the production of drugs.
The aim of the work is to standardize the cream under the conditional name «Saprocream» 
for use in veterinary medicine as a wound healing agent, development of methods of identification 
and quantification and their validation.
2. Materials and methods
2.1. Materials
Production of test samples of cream. Test samples of emulsion cream type o/v, containing 
15 % aqueous extract of sapropel (AES) and 10 % oily extract of sapropel (OES), 6 % emulsi-
fier No. 1, 1 % cetylstearyl alcohol, preservatives – 0.01 % nisin, 0.1 % euksil K 100 and purified 
water up to 100 g [14], were made by phase inversion by the following technology: the aqueous 
phase (purified water, AES, preservatives) was heated to a temperature of 70 ± 5 °C and added to 
the oil phase (OES, emulsifier No. 1, cetylstearyl alcohol). The resulting mixture was emulsified 
using a Polytron PT 3100 D homogenizer («Kinematica AG», Switzerland) for 15 min at a speed 
of 5000 rpm. At a temperature of 70 ± 5 °C, the remaining aqueous phase was added and emulsified 
for 5 min at a speed of 5000 rpm. Cooled to room temperature [15].
Reagents. Preparation of 0.1 M alkaline solution of sodium diphosphate (Na4P2O7×10H2O), 
0.4 М solution of chromium mixture, 0.2 M solution of Mohr’s salt ((NH4)2SO4×FeSO4×6H2O) 
and 0.2 % N-phenylanthranilic acid solution [19].
2.2. Methods
Description in accordance with the requirements of the pharmacopoeial article of the European 
Pharmacopoeia of the 10th edition «Semi-solid preparations for cutaneous application» p. 935 [20].
Odour. EP 10th ed., Vol. 1, 2.3.4., p. 133.
Homogeneity. The homogeneity of the cream and gel samples was determined by the me-
thod described in SPhU 1.0, p. 511 [21].
рН. The pH value was measured according to EP 10th ed., Vol. 1, 2.2.3., p. 24–25. – poten-
tiometrically using a laboratory device pH-150-MI (LLC «Measuring Equipment», RF) [20].
Determination of thermal stability. To study the thermal stability of SDF for each sample 
used 5 glass tubes with a diameter of 15 mm and a height of 150 mm. The tubes were filled 
with (8–10) ml of test samples and placed in a thermostat brand TC-80 MG with a temperature 
of (42.5 ± 2.5) °C for 7 days. After that, the samples were transferred for 7 days in a refrigerator with 
a temperature of (6 ± 2) °C and then kept for 3 days at room temperature. Stability was determined 
visually: if no stratification was observed in any test tube, the sample was considered stable [22].
Determination of colloidal stability. For the test used a laboratory centrifuge T 62 with 
a set of tubes, a mercury thermometer with a range of measured temperatures from 0 to 100 °C 
and a partition price of 1 °C, as well as a stopwatch and a water bath. The tubes are filled to 2/3 vo-
lume (approximately 9 g) with the test samples so that the masses of the tubes with the drug do not 
differ by more than 0.02 g, and weighed to the nearest 0.01. at a temperature of (42.5 ± 2.5) °C for 
20 min, then wiped dry on the outside and placed in the sockets of the centrifuge. Centrifuge for 
5 min at 6000 rpm. The sample is considered stable if no stratification is observed in the tubes after 
centrifugation. If in at least one of the tubes there is a stratification of the sample or the separation 
of sediment, the analysis is repeated with new portions. If at least one test tube with stratification 
is detected during the repeated test, the sample is considered unstable [22].
Structural viscosity, мPа∙s of the veterinary drug was determined on a rotary viscometer 
with a shear rate gradient of 18.0 s–1 and a temperature of (20.0 ± 0.1) °C according to the method 
of EP 10th ed., Vol. 1, 2.2.3., p. 28–30 [20].
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Measurement of shear stress τ (PA or N/m2) and shear rate Dr (s–1) is carried out by increas-
ing the number of spindle revolutions from 20 to 100 rpm, achieving constant values at maximum 
rotation and further reducing the spindle speed 
Microbiological purity. The studies were performed in accordance with the requirements 
of EP 10th ed., Vol. 1, 2.6.12. p. 201, 2.6.13 p. 205 [20].
To study the validation characteristics (AES) used the approach to the validation of BAS 
in herbal preparations, described in the literature [23]. The specificity of this analytical procedure 
was proved by determining the number of milligrams of HA in the studied AES by volumetric 
titration. To increase the specificity of the redox technique, a control experiment was performed 
in parallel.
The criterion for the acceptability of the proposed method is the linear relationship between 
the concentration of the total mass fraction of HA on the mass of the sample AES. When determin-
ing the linearity was performed titration of each sample in a concentration of from 80 % to 120 % 
of the selected at least three times.
Statistical analysis of the data was performed using the Shapiro-Wilk test using the soft-
ware package GraphPad Prism 5.04 (GraphPad Software Inc., USA).
The result was calculated using two-way analysis of variance with the Bonferroni post 
hoc test. For each result obtained, the arithmetic mean (M) and the standard error of the arithmetic 
mean (m) were determined. The difference between the means was considered statistically signi-
ficant if p was less than 0.05.
3. Experimental procedures
Methods of identification and quantification in the studied cream were developed – the 
presence of OES was determined by identifying substances of carotenoid structure and chlorophyll 
and AES by quantitative determination of the total mass fraction of HA.
3.1. Identification of sapropel oil extract in the cream
Thin layer chromatography (TLC) (EP 10th ed., Vol. 1, 2.2.27., p. 47–48). To identify sub-
stances of carotenoid structure used the method of TLC compared with a standard solution of 
β-carotene. The tests were performed using acetone extract from the cream on TLC plates with 
a layer of silica gel and a fluorescent indicator F254 (firm «Merk» Merck Silica gel F254), mobile 
phase petroleum ether-diethyl ether (10:3.5). Detection was performed after drying of chromato-
grams in UV radiation and treatment of chromatograms with 10 % solution of phosphoromolybdic 
acid and drying with heating in daylight.
Test solution: to 1.0 g of cream was added 10 ml of acetone and mixed with a magnetic mixer 
in a conical flask with a capacity of 100 ml for 30 minutes. The solution was filtered through a blue 
tape paper filter.
Comparison solution: 5 mg of PRS β-carotene was dissolved in 10 ml of hexane.
Plate: TLC plate with silica gel layer P and fluorescent indicator F254 or identical. 
Moving phase: petroleum ether P – diethyl ether P (10:3.5).
Sample volume: 5 μl of the test solution and the comparison solution in strips, thoroughly 
dried the application of the strips.
The distance that the moving phase must pass: 10 cm from the starting line.
Drying: in the air for 20 minutes.
Detection А: viewed in UV radiation at a wavelength of 254 nm.
Results А: the chromatograms showed a zone of yellow fluorescence absorption in the 
upper part.
Detection В: sprayed with a 10 % solution of phosphorus-molybdic acid, heated in an oven 
at a temperature of 60 °C for at least 10 minutes.
Results В: blue spots were observed on a green-yellow background (carotenoids and their 
derivatives, chlorophyll). 
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The absorption spectrum of hexane extract from the cream in the range from 500 nm to 
750 nm should have a maximum absorption at a wavelength of 670 ± 2 nm, which coincides with the 
maximum absorption of hexane solution OES.
3.2. Quantitative determination of aqueous extract of sapropel in the cream. 
Quantitative determination of the total mass fraction of humic acids in the cream. The total 
mass fraction of humic acids (HA) was determined by the method described in the literature, after 
oxidation of HA by the method of I. V. Tyurin in the modification of B. A. Nikitin and titration 
with Mohr’s salt [14].
The total mass fraction of humic acids (HA) in the test sample of cream was determined 
after extraction of humic acids from a portion of the cream, their deposition and oxidation by the 
method of I. V. Tyurin in the modification of B. A. Nikitin and titration with Mohr’s salt [19].
Extraction of humic acids from a sample of cream. 5,000 g of cream (exact portion) was 
placed in a 100 ml conical flask, 20 ml of hexane was added, stirred with a magnetic stirrer for 
5 minutes, transferred to a separatory funnel, 2 ml of saturated potassium chloride solution was 
added, shaken and left to stratify. The aqueous layer (bottom) was poured into a 250 ml flask (flask A), 
100 ml of alkaline sodium diphosphate solution was added and stirred for 1 h on a shaker.
The resulting suspension was transferred to a centrifuge tube and centrifuged for 15 min at 
2000 rpm, decanted into a 1000 ml conical flask (flask B) and washed twice with 100 ml of 1 % 
sodium hydroxide solution, centrifuging each time and pouring the solution into flask B. The con-
tents of flask B were filtered through a blue strip filter into a 1000.0 ml volumetric flask, made up 
to the mark with purified water P and mixed (solution to determine the total mass fraction of HA).
Precipitation of humic acids. From a 1000 ml flask containing an alkaline HA solution, 
50.0 ml of the solution was taken, transferred to a 100 ml conical flask and, while stirring, sulfuric 
acid concentrated to a pH of 2.0 to 3.5 was added dropwise. The pH of the solution was measured 
potentiometrically. The flask was heated on a boiling water bath for 30 minutes, cooled and left for 
16 hours for complete precipitation. HA was filtered through a blue strip filter. The filter cake and 
the flask in which the HA was precipitated were washed with 0.05 M sulfuric acid solution 3 times 
in 10 ml to give a clear filtrate.
The funnel with the precipitate on the filter is inserted into a volumetric flask with a capa-
city of 100.0 ml and dissolved the precipitate HA with hot 0.05 M sodium hydroxide solution. 
The filter was washed with hot sodium hydroxide solution until the precipitate was completely 
dissolved and a clear filtrate was obtained. The resulting alkaline HA solution was cooled to room 
temperature and the volume of the flask was adjusted to 0.05 M with sodium hydroxide solution.
Oxidation of humic acids by the method of I. V. Tyurin in the modification of B. A. Nikitin and 
titration with Mohr’s salt. In a conical flask with a capacity of 100 ml was placed 20.0 ml of alka-
line HA solution, the solution was evaporated in a boiling water bath to dryness without drying it.
To a conical flask with dry residue was added 10 ml of 0.4 M solution of chromium mixture. 
The solution was topped up slowly, washing the walls of the flask thoroughly. The flask was closed 
with a funnel and placed in an oven for 20 min at a temperature of 150–160 °C. After cooling, the 
flask was removed from the funnel, washed with purified water, 6 drops of 0.2 % N-phenylanthra-
nilic acid solution were added and titrated with 0.2 M Mora salt solution until the color changed 
from cherry red to green.
A control study was performed in parallel.






− × ×( ) .
,
1 0 41 36  (1)
where V1 – volume of Mohr’s salt solution spent on titration of control experiment, ml; V0 – volume 
of Mohr’s salt solution spent on titration of analytical sample, ml; K – correction factor for Mohr’s 
salt solution; M – the weight of the sample of the test sample, g.
The amount of HA in 1 g of cream should be at least 8.0 mg.
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4. Results 
Identification. The presence of OES was determined in the test cream by identifying caro-
tenoids and chlorophylls and AES by quantifying the total mass fraction of HA.
To identify substances of carotenoid structure used the method of TLC compared with 
a standard solution of β-carotene.
The chromatographic profile of the acetone extract from the cream should coincide with 
the chromatographic profile of the reference solution (PRS β-caroten): two spots of yellow fluo-
rescence with Rf about 0.60 and 0.80 (detection A); two gray spots with Rf = 0.09 and Rf = 0.14, 
blue spots Rf = 0.27; Rf = 0.36; Rf = 0.67; Rf = 0.80. Other zones are also observed on the chromato-
gram of the test solution (Fig. 2).
Fig. 2. Chromatogram of test solution and reference solution
The method of absorption spectrophotometry in the visible region was used to identify OES 
chlorophylls. The absorption spectrum of hexane extraction from the cream in the range from 
500 nm to 750 nm should have a maximum absorption at wavelengths of 670 ± 2 nm (Fig. 3, a), 
which coincides with the maximum absorption of hexane solution OES (Fig. 3, b).
The results of quantification of the total mass fraction of HA in six samples of cream and 
metrological characteristics of the average result are given in Table 1.
The specificity of this analytical procedure was demonstrated by determining the number 
of milligrams of HA in the test dosage form with AES by volume titration. The results are given 
in Table 2 and are shown in Fig. 4.
It was found that there is a linear relationship between the concentration of the total mass 
fraction of HA on the mass of the AES sample with a correlation coefficient of 0.9981 (³ 0.9981), 
the angular coefficient of linear dependence (b) is 0.99, the free member of the linear depen-
dence (a) – 0.30 ≤ 2.60.
Precision and accuracy studies were performed on nine determinations in the concentration 
range from 80 % to 120 % according to the selected method (Table 3).
The obtained results show that the method is precise, because the value of the relative confi-
dence interval is less than the critical value for the convergence of the results: D % = 1.34 ≤ 1.60 and 
the criterion of insignificance of systematic error d = 0.51 is fulfilled.
As a result of quantitative analysis, it was found that the total mass fraction of HA in cream 
samples with sapropel extracts is 0.828 %.
Based on the obtained data, it is proposed to introduce requirements for the quantitative con-
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Fig. 3. Absorption spectrum: a – hexane extraction from the cream; b – hexane solution of OES
Table 1
Metrological characteristics of the average result of quantitative determination of the total mass fraction 
of HA in the cream with sapropel extracts
Series No.
The content of the total 
mass fraction of humic 
acids, mg
S2 S Dx D , % e, %
1 8.10
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Table 2
Calculation of linearity parameters of the method of quantitative determination of the mass fraction of HA 










Fig. 4. The dependence of the concentration of the total mass fraction of HA on the mass  
of the sample of the test cream
Table 3
The results of the study of the precision of the method of quantitative determination of the total mass fraction 
of HA in the cream
Parameter Value Criterion 1 Criterion 2 Conclusion
Precision ∆Z 1.34 ≤ 1.60 Sustained by the first criterion
Table 4
Cream quality indicators included in the MQC project
Indicator Acceptable limits The results  of the analysis




TLC. The chromatographic profile of the acetone extract from the cream 
must coincide with the chromatographic profile of the reference solution (PRS 
β-carotene).
Method of absorption spectrophotometry in the visible area.
The absorption absorption spectrum of hexane extraction shall have a maximum 
absorption at wavelengths of 670 ± 2 nm in the range from 500 nm to 750 nm
Corresponds
Corresponds
Homogeneity Must be homogeneous Homogeneous
рН 6.0–7.0 6.6 ± 0.1
Colloidal stability Must be stable Stable
Thermal stability Must be stable Stable
Structural viscosity, мPа∙s. 6990 ± 30 mPа∙s. Corresponds
Microbiological purity
The total number of aerobic microorganisms (TAMS) is 102 CFU/ml.
Total pure yeast and mold (TYMC) – 101 CFU/ml.
Absence of Staphylococcus aureus in 1 ml.
Absence of Pseudomonas aeruginosa in 1 ml
Corresponds
Quantitative determination
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It is experimentally confirmed that the indicator of microbiological purity of the drug 
«Sapro cream» meets the requirements of EP 10.0 which are put forward to drugs for dermal use.
The cream is standardized according to the following indicators: description, identification 
of active substances, homogeneity, colloidal and thermal stability, pH, structural viscosity, quanti-
tative determination of active substances, microbiological purity.
4. Discussion
To determine carotenoids and chlorophylls in medicinal plant raw materials use the me-
thod of liquid chromatography-mass spectrometry [24], high performance liquid chromatogra-
phy (HPLC) [25]. For simultaneous detection of carotenoids and chlorophylls in sapropels use the 
method of high-performance liquid chromatography (HPLC) (HPLC-UV-VIS) [26], as well as the 
method of HPLC with photodiodes with UV – detection in the visible region and atmospheric 
pressure (High performance liquid chromatography with photodiode array UV – Vis detection and 
atmospheric pressure chemical ionization mass spectrometry) [27] and Raman spectroscopy [28].
The most reliable methods of standardization of total drugs, drugs in which biological ac-
tivity is associated with a large number of compounds, many of which are of unknown structure, 
concentrations of which can vary widely, are the determination of conditional concentrations by 
spectrophotometry and control of signal components by chromatographic methods [23].
The advantage of the proposed methods of identification and quantification of biologically 
active compounds contained in the veterinary cream and provide its biological effect is a separate 
determination of carotenoids, chlorophyll and HA available methods, which allows to standardize 
the veterinary agent.
Study limitations. As a disadvantage, it should be noted that the amount of HA may differ 
in the sapropels of different lakes, as their chemical composition depends on a number of fac-
tors [29, 30]. HAs have an indeterminate composition, which varies depending on the origin, pro-
duction process and functional groups present in their structure [31], so the quantitative and qua-
litative profile of these compounds in the development of standardization methods may differ for 
different deposits.
Prospects for further research. According to the results of the research, analytical docu-
mentation has been developed for the cream under the conditional name «Saprocream», which makes 
it possible to introduce it into industrial production for the prevention and treatment of mastitis in cows.
In the future it is planned to develop «Saprocream» when used in lactating cows and de-
termine its impact on milk quality, as well as testing other types of pharmacological activity and 
determining the prospects for the use of the cream for the treatment of other diseases.
5. Conclusions
Methods of identification of carotenoid substances in the cream with sapropel extracts by 
the TLC method in comparison with the standard solution of β-carotene and chlorophylls by the 
method of absorption spectrophotometry in the visible area have been developed.
A method for quantitative determination of the total mass fraction of HA after their ex-
traction from the cream, precipitation and oxidation has been developed and this method has been 
validated for linearity and precision.
To the specification for the cream with sapropel extracts under the conditional name «Sapro-
crem» are added sections: «Description», «Identification», «pH», «Quantitative determination», 
«Microbiological purity», «Structural viscosity», as well as sections that regulate requirements 
for packaging, storage conditions and shelf life of the developed drug (homogeneity, colloidal and 
thermal stability).
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